[HTML][HTML] Limiting “evergreening” for a better balance of drug innovation incentives

MB Stanbrook - CMAJ, 2013 - Can Med Assoc
The global pharmaceutical industry's most important new development this year may have
taken place in the courtroom rather than in a laboratory. In April 2013, India's Supreme Court …